Genentech Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.As of November 2014, Genentech employed nearly 12,900 people. In July 2014, Genentech announced its acquisition of Seragon for up to $1.725 billion.